ArticleProceedings of the National Academy of Sciences of the United States of America2019

Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma.

Eva A Ebbing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.